» Articles » PMID: 10482904

The Recombinant 5-HT1A Receptor: G Protein Coupling and Signalling Pathways

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1999 Sep 14
PMID 10482904
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

The 5-hydroxytryptamine 5-HT1A receptor was one of the first G protein coupled receptors whose cDNA and gene were isolated by molecular cloning methods. Transfection of the cDNA of this receptor into cells previously bearing no 5-HT receptors has resulted in the acquisition of large amounts of information regarding potential signal transduction pathways linked to the receptor, correlations of receptor structure to its various functions, and pharmacological properties of the receptor. Transfection studies with the 5-HT1A receptor have generated critical new information that might otherwise have been elusive. This information notably includes the discovery of unsuspected novel signalling linkages, the elucidation of the mechanisms of receptor desensitization, the refinement of models of the receptor pharmacophore, and the development of silent receptor antagonists, among others. The current review summarizes the most important studies of the recombinant 5-HT1A receptor in the decade since the identification of its cDNA.

Citing Articles

Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer's disease.

Pierson S, Kolling L, James T, Pushpavathi S, Marcinkiewcz C Pharmacol Res. 2024; 203:107171.

PMID: 38599469 PMC: 11088857. DOI: 10.1016/j.phrs.2024.107171.


Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase.

Calapai F, Mannucci C, McQuain L, Salvo F Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895891 PMC: 10610535. DOI: 10.3390/ph16101420.


5-HT and 5-HT receptor interaction and co-clustering regulate serotonergic neuron excitability.

Benhadda A, Delhaye C, Moutkine I, Marques X, Russeau M, Le Magueresse C iScience. 2023; 26(8):107401.

PMID: 37575185 PMC: 10415917. DOI: 10.1016/j.isci.2023.107401.


G Protein Signaling Bias at Serotonin 1A Receptor.

Alabdali R, Franchini L, Orlandi C Mol Pharmacol. 2023; 104(5):230-238.

PMID: 37567783 PMC: 10586511. DOI: 10.1124/molpharm.123.000722.


The Serotonin 1A (5-HT) Receptor as a Pharmacological Target in Depression.

Smith A, Harmer C, Cowen P, Murphy S CNS Drugs. 2023; 37(7):571-585.

PMID: 37386328 DOI: 10.1007/s40263-023-01014-7.


References
1.
Mangel A, Raymond J, Fitz J . Regulation of high-conductance anion channels by G proteins and 5-HT1A receptors in CHO cells. Am J Physiol. 1993; 264(3 Pt 2):F490-5. DOI: 10.1152/ajprenal.1993.264.3.F490. View

2.
Brown K, Park S, Kanno T, Franzoso G, Siebenlist U . Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci U S A. 1993; 90(6):2532-6. PMC: 46122. DOI: 10.1073/pnas.90.6.2532. View

3.
Chanda P, Minchin M, Davis A, Greenberg L, Reilly Y, McGregor W . Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor. Mol Pharmacol. 1993; 43(4):516-20. View

4.
Banerjee P, Berry-Kravis E, Dawson G . Heterologous expression of the serotonin 5-HT1A receptor in neural and non-neural cell lines. Biochem Biophys Res Commun. 1993; 192(1):104-10. DOI: 10.1006/bbrc.1993.1387. View

5.
Arthur J, Casanas S, Raymond J . Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors. Biochem Pharmacol. 1993; 45(11):2337-41. DOI: 10.1016/0006-2952(93)90208-e. View